Aspiration of Breast for Stage 2 Breast Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Stage 2 Breast Cancer+27 MoreAspiration of Breast - Procedure
Eligibility
18+
Female
What conditions do you have?
Select

Study Summary

This trial is looking into whether or not nipple aspirate fluid can help detect breast cancer earlier on than other methods such as mammograms or breast examinations.

Eligible Conditions
  • Stage 2 Breast Cancer
  • Stage IIIB Breast Cancer
  • Triple Negative Breast Cancer
  • Stage IA Breast Cancer
  • Stage II Breast Cancer
  • Stage IIA Breast Cancer
  • Stage III Breast Cancer
  • Stage IV Breast Cancer
  • HER2/Neu Negative Breast Cancer
  • Luminal A Breast Cancer
  • Invasive Lobular Carcinoma
  • Stage 1 Breast Cancer
  • Stage IB Breast Cancer
  • Stage IIB Breast Cancer
  • Estrogen Receptor Negative Breast Cancer
  • Progesterone Receptor Negative Breast Cancer
  • Stage IIIA Breast Cancer
  • Healthy Subjects
  • HER2 Positive Breast Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Up to 1 year

Up to 1 year
Biomarkers expression levels

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Diagnostic (nipple aspiration fluid)
1 of 1

Experimental Treatment

100 Total Participants · 1 Treatment Group

Primary Treatment: Aspiration of Breast · No Placebo Group · N/A

Diagnostic (nipple aspiration fluid)Experimental Group · 2 Interventions: Aspiration of Breast, Biospecimen Collection · Intervention Types: Procedure, Procedure
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Biospecimen Collection
2004
Completed Phase 1
~670

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 1 year

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,073 Previous Clinical Trials
41,138,808 Total Patients Enrolled
Ohio State University Comprehensive Cancer CenterLead Sponsor
287 Previous Clinical Trials
285,913 Total Patients Enrolled
William Carson, MD4.86 ReviewsPrincipal Investigator - Ohio State University Comprehensive Cancer Center
4 Previous Clinical Trials
150 Total Patients Enrolled
5Patient Review
I couldn't have been more pleased.

Eligibility Criteria

Age 18+ · Female Participants · 8 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
Women who have not had surgery, radiotherapy, or chemotherapy within 30 days of enrollment are not eligible to participate in this study.
Healthy subjects must not have a history of breast cancer and must not currently be diagnosed with any other form of cancer.
Women who are interested in being a part of this study must be willing to keep the clinic informed of their breast health status for one year.
You must currently have breast cancer that is known to exist in order to be eligible for this program.
Cannot currently have any other type of cancer, except breast cancer.
The following medical conditions must be more than one year from pregnancy or lactation in order for breast cancer to be covered: breast cancer.
Healthy subjects must be at least one year from pregnancy and lactation.
healthy subjects: must be willing to have a clinical breast exam and/or mammogram performed or reviewed by an Ohio State University (OSU) radiologist within the past 90 days prior to their NAF procedure